Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2008
11/27/2008WO2008143545A1 Agent for stimulating lymphatic drainage
11/27/2008WO2008142513A2 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
11/27/2008WO2008142134A1 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
11/27/2008WO2008142094A1 Triazol compounds for treating biofilm formation
11/27/2008WO2008141438A1 Gabaergic modulators for treating airway conditions
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008046087A3 Spiro compounds and their uses as therapeutic agents
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008US20080293823 Methods and Compositions For Treating Sleep-Related Breathing Disorders
11/27/2008US20080293819 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293813 Compositions and Methods
11/27/2008US20080293802 Chemical Compounds
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293788 Methods and Compositions for the Treatment of Pulmonary Diseases
11/27/2008US20080293775 Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293742 Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293714 Tec Kinase Inhibitors
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293121 Human dnase i hyperactive variants
11/27/2008US20080292713 Respirable Powders
11/27/2008US20080292709 Kits for dhea and dhea-sulfate for the treatment of chronic obstructive pulmonary disease
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292698 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292629 System Clock Generation Circuit
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292611 Novel methods of treatment and delivery modes
11/27/2008US20080292595 AAV vectors for gene delivery to the lung
11/27/2008US20080292563 Inhalable Powder Containing Tiotropium
11/27/2008US20080292562 Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2687545A1 Agent for stimulating lymphatic drainage
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2686683A1 Il-33 in inflammatory disease
11/27/2008CA2686286A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
11/27/2008CA2685112A1 Triazol compounds for treating biofilm formation
11/27/2008CA2684046A1 Treatment of allergic disease with immunomodulator compounds
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1994930A1 Triazol compounds for treating biofilm formation
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1993564A1 Method and composition for treating allergic diseases
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993521A1 Compositions comprising apocynin , ginkgo and ginger and uses thereo
11/26/2008EP1763528B1 Pyrazolopyridine derivatives
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008CN101312950A Alkyl sulfoxide quinolines as nk-3 receptor ligands
11/26/2008CN101312729A Treatment of asthma and copd using triple-combination therapy
11/26/2008CN101312721A Organic compounds comprising a glycopyrronium salt
11/26/2008CN101310747A Novel traditional Chinese drug composition for treating apoplectic hemiplegia and removing phlegm
11/26/2008CN101310746A External remedy for relieving cough and asthma
11/26/2008CN101310735A Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof
11/26/2008CN101310722A New formulation of levamisole for treating asthmatia
11/26/2008CN101310713A New use of chloral hydrate for preparing pulmonary fibrosis disease
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100436414C Azabicyclo derivatives as muscarinic receptor antagonists
11/26/2008CN100435845C Live attenuated vaccine against porcine pleuropneumonia
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/20/2008WO2008141119A2 Modulators of cftr
11/20/2008WO2008140653A2 Humaneered anti-factor b antibody
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139703A1 Agent for treatment of pulmonary disease
11/20/2008WO2008138939A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008WO2008138917A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138658A2 Pharmaceutical compounds comprising abasic oligonucleotides
11/20/2008WO2008138123A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008WO2008101052A8 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
11/20/2008WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways
11/20/2008WO2008062450A3 Crystalline polymorphs of ciclesonide
11/20/2008US20080287520 Use of Melatonin in Preventing Postoperative Complications
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 878